The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?
 
Grant Richard Williams
Honoraria - Cardinal Health; Carevive Systems
 
Mustafa Al-Obaidi
No Relationships to Disclose
 
Joseph Rower
No Relationships to Disclose
 
Christian Harmon
No Relationships to Disclose
 
Chen Dai
No Relationships to Disclose
 
Edward Acosta
No Relationships to Disclose
 
Smith Giri
Honoraria - CareVive; OncLive
Research Funding - Carevive Systems; Pack Health
 
William Zamboni
Employment - ChemoGLO (I); Glolytics (I)
Leadership - ChemoGLO; ChemoGLO (I); Glolytics; Glolytics (I)
Stock and Other Ownership Interests - ChemoGLO; ChemoGLO (I); Glolytics; Glolytics (I)
Consulting or Advisory Role - BlueLink; ChemoGLO; Ellipses Pharma; GlaxoSmithKline; Glolytics; Merrimack; OBI Pharma; Syros Pharmaceuticals
Research Funding - CBT Pharmaceuticals; ChemoGLO; Genentech; Glolytics; MabVax; Merrimack; Meryx Pharmaceuticals; OBI Pharma
Patents, Royalties, Other Intellectual Property - Biomarkers of MPS Function (controlled by Glolytics) and MPS FcRs (controlled by UNC); ChemoGLO Wipe Kits and HDClean cleaning products
Travel, Accommodations, Expenses - ChemoGLO; Glolytics; Syros Pharmaceuticals
 
Andrew T. Lucas
No Relationships to Disclose
 
Shlomit Strulov Shachar
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer; Roche
 
Olumide B. Gbolahan
Consulting or Advisory Role - Exelixis; Merck Sharp & Dohme
 
Jeffrey A. Meyerhardt
Honoraria - Cota Healthcare; Taiho Pharmaceutical
Research Funding - Boston Biomedical (Inst)
 
Bette Jane Caan
No Relationships to Disclose
 
Smita Bhatia
No Relationships to Disclose